Fibronectin inhibits the cytotoxic effects of ricin A chain on endothelial cells

International Journal of Immunopharmacology

Volumn 18, Issue 6-7, 1996, Pages 355-361

  Baluna, Roxana ^a   Ghetie, Victor ^a   Oppenheimer Marks, Nancy ^b   Vitetta, Ellen S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Endothelial cells; Monoclonal antibody; Toxin

Indexed keywords

FIBRONECTIN; RICIN A;

ARTICLE; CELL CULTURE; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INDICATORS AND REAGENTS; IODINE RADIOISOTOPES; RICIN; SURFACE PROPERTIES; THYMIDINE; UMBILICAL CORD;

EID: 0030158783     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(96)00043-4     Document Type: Article

References (22)

1. Albelda, S. M., Daise, M., Levine, E. M. & Buck, C. A. (1989) Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J. clin. Invest., 83, 1992-2002.
2. Amlot, P. L., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P. E., Uhr, J. W. & Vitetta, E. S. (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood, 82, 2624-2633.
3. Dejana, E. (1993) Endothelial cell adhesive receptors. J. Cardiol. Pharmac., 21, S18-S21.
4. Fraker, P. J. & Speck, J. C. Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. biophys. Res. Commun., 80, 849-857.
5. Frankel, A. E., Tagge, E. P. & Willingham, M. C. (1995) Clinical trials of targeted toxins. Semin. Cancer Biol., 6, 307-317.
6. Ghetie, M., May, R. D., Till, M., Uhr, J. W., Ghetie, V., Knowles, P. P., Relf, M., Brown, A., Wallace, P. M., Janossy, G., Amlot, P., Vitetta, E. S., Thorpe, P. E. (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res., 48, 2610-2617.
7. Grossbard, M. L., Lambert, J. M., Goldmacher, V. S., Spector, N. L., Kinsella, J., Eliseo, L., Coral, F., Taylor, J. A., Blattler, W. A., Epstein, C. L. & Nadler, L. M. (1993) Anti-B4-blocked ricin - a phase-I trial of 7-day continuous infusion in patients with B-cell neoplasms. J. clin. Oncol., 11, 726-737.
8. Y damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome. Clin. Cancer Res., 1, 1589-1594.
9. Lampugnani, M. G., Resnati, M., Dejana, E. & Marchisio, P.C. (1991) The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol., 112, 479-490.
10. Luscinskas, F. W. & Lawler, J. (1994) Integrins as dynamic regulators of vascular function. FASEB J., 8, 929-938.
11. Oliver, M. H., Harrison, N. K., Bishop, J. E., Cole, P. J. & Laurent, G. J. (1989) A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci., 92, 513-518.
12. Re, F., Zanetti, A., Sironi, M., Polentarutti, N., Lanfrancone, L., Dejana, E. & Colotta, F. (1994) Inhibition of anchoragedependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol., 127, 537-546.
13. Ruoslahti, E. (1991) Integrins. J. clin. Invest., 87, 1-5.
14. Saba, T. M., Blumenstock, F. A., Shah, D. M., Landaburu, R. H., Hrinda, M. E., Deno, D. C., Holman, J. J. J., Cho, E., Pherlan, C. & Cardarelli, P. M. (1986) Reversal of opsonic deficiency in surgical, trauma and burn patients by infusion of purified human plasma fibronectin. Am. J. Med., 80, 229-240.
15. Saba, T. M., Jaffe, E. (1980) Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am. J. Med., 68, 577-594.
16. Sausville, E. A., Headlee, D., Stetler-Stevenson, M., Jaffe, E. S., Solomon, D., Figg, W. D., Herdt, J., Kopp, W. C., Rager, H., Steinberg, S. M., Ghetie, V., Uhr, J., Wittes, R. E. & Vitetta, E. S. (1995) Continuous infusion of the anti-CD22 immunotoxin, IgG-RFB4-SMPT-dgA in patients with B cell lymphoma: a phase I study. Blood, 85, 3457-3465.
17. Soler-Rodriguez, A. M., Ghetie, M. A., Oppenheimer-Marks, J., Uhr, J. W. & Vitetta, E. S. (1993) Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Exp. Cell Res., 206, 227-239.
18. Sottile, J. & Wiley, S. (1994) Assembly of amino-terminal fibronectin dimers into the extracellular matrix. J. biol. Chem., 269, 17192-17198.
19. Vallera, D. (1994) Immunotoxins: will their clinical promise be fulfilled?. Blood, 83, 309-317.
20. Vitetta, E. S., Stone, M., Amlot, P., Fay, J., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J. W. & Thorpe, P. E. (1991) A phase I immunotoxin trial in patients with B cell lymphoma. Cancer Res., 51, 4052-4058.
21. Vitetta, E. S., Thorpe, P. E. & Uhr, J. W. (1993) Immunotoxins: magic bullets or misguided missiles. Immunol. Today, 14, 252-259.
22. Zikria, B. A. (1994). Mechanisms of multiple system organ failure. In Reperfusion Injuries and Clinical Capillary Leak Syndrome (eds Zikria, B. A., Oz, M. O. and Carlson, R. W.) pp. 443-489. Futura Publishing Co., New York.